Journal of Biomaterials Science , 2008
Crosses the Blood-Brain Barrier Unlike many peptides and growth factors, Dihexa is orally bioavailable and crosses the BBB , meaning it can be taken as an oral tablet and still reach brain tissues in therapeutic concentrations
This BPC-157 TB500 combo is widely investigated for amplified effects on soft tissue repair, joint and ligament recovery, inflammation modulation, and accelerated healing dynamics in preclinical injury models
View the complete Dihexa research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ
Target: 7501000 mcg daily by Weeks 512
Such medicines contain a decongestant drug, known as a sympathomimetic